MegnaCur

A new compoundA new treatment for GERD/Acid RefluxFrom

www.nanomeda.comwww.nanosgroup.com

Do you want to go with this PPI Drugs?Big Problem?

• PPI drugs proven to cause vitamin B12 deficiency

• Tuesday, December 17, 2013 by: PF LouisTags: PPI drugs, B12 deficiency, vitamin supplements

No!Wait!We have an option for you.100% safe and effective solution for GERD/Acid Reflux

Big Problem

• According to a new study in the Journal of the American Medical Association, proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs) suppress gastric acid production, which can mean that the Vitamin B12 in food is not properly absorbed into the body. Vitamin B12 deficiency is linked to serious health complications, such as anemia, nerve damage, and dementia

• The most commonly used PPIs are Prilosec, Prevacid, Nexium, Protonix, and Aciphex. The most popular H2RAs include Zantac, Pepcid, and Tagamet.

MegnaCur-Discovery

Mg

A newly discovered Compound for Acid Reflux/GERD

GERD/Acid Reflux

Market Size

• In recent years, GI prescriptions have remained one of the world’s largest therapeutic markets, with sales of more than $20 billion

• Given the large public need and the propensity for high returns, the gastroenterology market is set to expand. As an increasing pool of smaller specialty pharmaceutical players recognize the need and importance of developing innovative treatments to restore normal function of the GI system and improve patients’ quality of life, the doors to improved GI health are opening, and opportunity

Established

• A newly discovered compound• Proof of concept• No generic cliff• Patent protection• Pilot scale production• Raw material qualification• Manufacturing and QC protocols• Machinery identified• Formulation

Product

• Capsule• Tablet• Syrup• Soft drink• Chewing gum

Ready to Launch

Next

• cGMP manufacturing• Preclinicals• NDA• Clinical trials• Market/Partners/Exit

Funds

• $3million 1st round• 3-5 years for exit and product launch• We provide patent protection• Direct investment on clinical trials

Contact To Join Us

Mewa Singh, PhDmewasinghsandhu@hotmail.com609-902-7128www.nanomeda.comwww.nanosgroup.com

Opportunity for $20Billion Market

MegnaCur-A new compoundfor

GERD/Acid Reflux

Mg